Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2057-3804
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia ; volume:2 ; number:1 ; day:14 ; month:10 ; year:2016 ; pages:1-4 ; date:12.2016
Cardio-Oncology ; 2, Heft 1 (14.10.2016), 1-4, 12.2016
- Creator
-
von Korn, Pia
- Contributor
-
Vogt, Manfred
Oberhoffer, Renate
Ewert, Peter
Müller, Jan
SpringerLink (Online service)
- DOI
-
10.1186/s40959-016-0016-0
- URN
-
urn:nbn:de:1111-2016111329354
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- von Korn, Pia
- Vogt, Manfred
- Oberhoffer, Renate
- Ewert, Peter
- Müller, Jan
- SpringerLink (Online service)
Other Objects (12)
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
Pregnancy with acute myeloid leukemia
Chronic myeloid leukemia in India
Current treatment of juvenile myelomonocytic leukemia
Immunogenicity of leukemia stem cells in acute myeloid leukemia
Current developments in acute myeloid leukemia
CDK9 inhibitors in acute myeloid leukemia
FLT3 inhibitors in acute myeloid leukemia
Chronic Myeloid Leukemia Preceded by Tuberculosis
Treatment of Relapsed Acute Myeloid Leukemia
Precision therapy for acute myeloid leukemia
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
Pregnancy with acute myeloid leukemia
Chronic myeloid leukemia in India
Current treatment of juvenile myelomonocytic leukemia
Immunogenicity of leukemia stem cells in acute myeloid leukemia
Current developments in acute myeloid leukemia
CDK9 inhibitors in acute myeloid leukemia
FLT3 inhibitors in acute myeloid leukemia
Chronic Myeloid Leukemia Preceded by Tuberculosis
Treatment of Relapsed Acute Myeloid Leukemia
Precision therapy for acute myeloid leukemia
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
Pregnancy with acute myeloid leukemia
Chronic myeloid leukemia in India
Current treatment of juvenile myelomonocytic leukemia
Immunogenicity of leukemia stem cells in acute myeloid leukemia
Current developments in acute myeloid leukemia
CDK9 inhibitors in acute myeloid leukemia
FLT3 inhibitors in acute myeloid leukemia
Chronic Myeloid Leukemia Preceded by Tuberculosis
Treatment of Relapsed Acute Myeloid Leukemia